Stock Ratings / Health Care / PSNL / options

ALHC (67) FRNM (31) TRUP (64) FTRE (35) ⌘ Pro Terminal →

Personalis Inc. (PSNL) Options Positioning, Max Pain & Unusual Sweeps

$15.93 -0.47% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $15.89

Personalis Inc. (PSNL) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $1.70B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $15.89 (-0.27%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.3% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PSNL)Realized 20D OHLCV Swing Band: ±4.4%

Deterministic 5-Pillar Attribution (36/100 Composite)

🔍 WHY PSNL SCORES 36/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+10/20 pts (28% of score)

FRED Regime × Technicals: 79% of 52W Range • RSI-14 at 45.2 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (25% of score)

20D Institutional Volume Accumulation (±4.4% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$16.00-2.2% Next Q

Q2 (-2Q)

Grade D$15.65+1.3% Next Q

Q3 (-1Q)

Grade E$15.85+0.5% Next Q

Current

Grade D-$15.93-8.3% Hist 90D α

Trajectory: D (44) → D- (36)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a PSNL Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While PSNL currently carries a cautious 36/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($16.34) and Max Pain ($16.73) forces dealer call-delta covering toward $19.83.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PSNL• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “PSNL Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 36%NO 64%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±4.4%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (PSNL)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for PSNL.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PSNL)

✓Walkthrough of PSNL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PSNL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +188.59%▼ SUPPORT BREAKDOWN

2026-10-30O $15.86H $15.94L $15.65C $15.93VOL 2.36M

RES: $15.95SUP: $16.22SMA50: $16.34SMA200: $11.29

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PSNL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PSNL Butterfly Map → + Track PSNL →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -17.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PSNL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PSNL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PSNL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PSNL)

Health Care Rank #774 of 1016 ⚔️ ALHC vs PSNL Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PSNL vs. ALHC, FRNM, TRUP, FTRE)

Industry: Medical Specialities (41 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Personalis Inc. (PSNL) ranks #774 by composite RQD confidence (36/100, grade D-) and #286 by equity capitalization ($1.70B). Within this direct 5-issuer industry benchmark cohort, TRUP leads on earnings valuation at 68.2x trailing P/E, while ALHC leads on capital efficiency and profitability with 13.9% ROIC and — gross margin. ALHC currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with PSNL at 36/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PSNL ACTIVE Personalis Inc.	D-	36/100	—	22.7%	-35.0%	-0.47%	$1.70B	Benchmark Subject
ALHC Alignment Healthcare Inc.	C+	67/100	—	—	13.9%	-1.47%	$1.67B	/alhc-vs-psnl →
FRNM Freenome Inc.	E	31/100	—	—	-3.4%	-4.32%	$1.38B	/frnm-vs-psnl →
TRUP Trupanion Inc.	C	64/100	68.2x	16.1%	3.1%	+2.27%	$1.32B	/trup-vs-psnl →
FTRE Fortrea Holdings Inc.	D-	35/100	—	—	-35.0%	-10.61%	$2.20B	/ftre-vs-psnl →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001527753

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Personalis Inc. (PSNL) reported GAAP revenue of $69.6M (-17.7% vs. FY2024 revenue of $84.6M , and -5.2% cumulative change since FY2023) , GAAP net income of -$81.3M, operating cash flow of -$74.9M, and free cash flow of -$79.5M (-69.9% YoY). On the balance sheet, PSNL closed FY2025 with $334.2M in total assets against $0 in total debt (Altman Z-Score: 11.50, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$69.6M	-$81.3M	-$74.9M	-$79.5M	$334.2M	—
FY2024 (FY)	2024-12-31	$84.6M	-$81.3M	-$45.1M	-$46.8M	$270.3M	—
FY2023 (FY)	2023-12-31	$73.5M	-$108.3M	-$56.3M	-$56.3M	—	—

3. PSNL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PSNL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Personalis Inc. (NASDAQ: PSNL) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $15.93 (-0.47% 1D, market cap $1.70B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PSNL ranks #774 in composite RQD confidence.

How does PSNL compare to ALHC and FRNM in the Health Care sector?

Within the Health Care sector (Medical Specialities), PSNL carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 22.7%, and ROIC of -35.0%. By comparison, ALHC (Alignment Healthcare Inc.) holds a C+ grade (67/100 RQD, P/E N/A, ROIC 13.9%, cap $1.67B) and FRNM (Freenome Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -3.4%, cap $1.38B). Among the 5-stock peer group, TRUP leads on earnings multiple (68.2x) while ALHC leads on capital efficiency (13.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PSNL?

Per PSNL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001527753), Personalis Inc. generated $69.6M in revenue (-17.7% YoY), -$81.3M in net income, and -$79.5M in free cash flow against $334.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PSNL trading relative to its 50-day, 200-day, and 52-week technical levels?

PSNL last traded at $15.93 (-0.47% on volume of 749,266 shares), positioning the stock -2.51% below its 50-day simple moving average ($16.34) and +41.10% above its 200-day simple moving average ($11.29). Across its 52-week range of $4.96 to $18.89, PSNL sits at the 78.8% percentile with a 14-day RSI of 45.2 (NEUTRAL RANGE) and an implied next-earnings move of ±4.4% ($15.23 to $16.63).

PSNL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is PSNL's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for PSNL.

Direct Sub-Reports: PSNL RQD Cockpit PSNL 12M Forecast PSNL Earnings & Move PSNL Dividends & DRIP PSNL Insiders & 13F PSNL Whale Options PSNL Profit Sankey PSNL News & Why